PFKL and neuroblastoma: In this study, we investigated the antitumor effects of DMAMCL as a single agent and combined with chemotherapeutic agents (etoposide and cisplatin) against NB in vitro and in vivo, as well as the underlying mechanisms involving aerobic glycolysis and PFKL, a rate-limiting glycolysis enzyme.